Trump’s medical tariffs could significantly hurt these European healthcare firms

featured-image

FrankyDeMeyer Multinationals with significant operational footprints in Ireland, Germany, and Switzerland could bear the brunt of the Trump administration’s plans to impose tariffs on the pharmaceutical, life science, and medical device industry, global consultancy firm PwC said in a recent report..